nesthesia Vaginal delivery Labor epidural analgesia Caesarean IDO1 Inhibitor drug section Neuroaxial anesthesia Basic anesthesia Cesarean section indication Obstetric Elective Not specified499 338 (67.7) 147 (29.4) 14 (2.eight) 499 10 (two) 395 (79.15) 77 (15.43) 17 (three.four) 499 129 (25.85) 107/129 (83) 370 (74.15) 367/370 (99.2) 3/370 (0.eight) 370 174 (47.02) 133 (35.95) 63 (17.03)Conclusions: We didn’t obtain any important association between heparin dose or the time from final dose to delivery and bleeding or thrombotic complications. There was a high price of elective caesarean sections. The education on the pregnant woman for the optimal time for you to hold heparin before delivery is really a protected process with out significantly rising the risk of hemorrhagic or thrombotic complications. L. Perucci1; K. Pinto1; S. Silva1; E. Lage2; P. Teixeira2; A. Barbosa2; P. Alpoim2; L. Sousa2; L. Dusse2; A. TalvaniPB1300|Preeclampsia and Inflammatory Lipid Mediators: A Longitudinal StudyFederal University of Ouro Preto, Ouro Preto, Brazil; 2FederalUniversity of Minas Gerais, Belo Horizonte, Brazil PB1299|New Criteria for Assessing Hemostasis Problems in Pregnant Females with Chronic Kidney Disease I. Vasilenko1,2; I. Nikolskaya3; E. Shestero3; V. Metelin1,2; D. KassinaBackground: The levels of pro-inflammatory (e.g. leukotriene B4-LTB4) and pro-resolving (e.g. lipoxin A4-LXA4, and resolvin D1-RvD1) lipid mediators have been lately investigated in preeclampsia (PE). However, the production of these mediators all through gestation in both healthier and diseased contexts remains unclear. Aims: Investigate LTB4, LXA4, and RvD1 levels throughout gestation in pregnant girls with risk things for PE who either developed (N = 11) or did not develop (N = 7) the disease. Techniques: The ethics committee on the Federal University of Minas Gerais (#0618.0.203.0000) authorized the study protocol and all participants provided written informed consent. LTB4, LXA4 and RvD1 plasma levels were measured by immunoassays at three timepoints: 129, 209, and 304 weeks of gestation in each groups. Benefits: Table 1 shows patients’ clinical qualities.M.F. Vladimirsky Moscow Regional Clinical and Study Institute(MONIKI), Moscow, Russian Federation; 2A.N. Kosygin Russian State University, Moscow, Russian Federation; 3Moscow Regional Study Institute of Obstetrics and Gynecology (MONIIAG), Moscow, Russian D2 Receptor Modulator list Federation Background: The pregnancy of women with kidney disease is followed by improved frequency of gestational complications improvement for example endotheliosis, inflammation, oxidative stress, and hemostatic impairments. In this connection, a particular relevance is the search for objective and informative criteria for blood clotting issues in pregnant girls. Aims: The aim – to make less difficult the forecasting of probable complications in mother in addition to a child, evaluation of their condition severity, and therapy efficacy.ABSTRACT961 of|TABLE 1 Clinical characteristics of your studied pregnant womenParameters Age (years)aPregnant ladies who didn’t create PE (N = 17) 27 eight 23.6 (23.25.9) 1.0 (1.0.five) 112 11 71 9 114 9 71 4 115 (11020) 70 (708)aPregnant women who created PE (N = 11) 27 4 28.7 (22.51.8) 2.0 (1.0.0) 119 7 77 8 116 15 78 13 140 (13571) 110 (8915)P 0.598 0.073 0.235 0.271 0.138 0.313 0.072 0.001 0.001BMI at study admission (kg/m2)b Quantity of gestationsb SBP at study admission (mmHg)a DBP at study admission (mmHg) 2nd SBP measurement (mmHg)a 2nd DBP measurement (mmHg)a SBP ahead of delivery (mmHg)b DBP b